Company intelligence / Profile preview

Celltrion Healthcare Hungary

Budapest, Hungary

Ownership: Private
Employees: ~27
Development stage: Other

Overview

All marketed products have achieved major reimbursement and significant market share in the EU in rheumatoid arthritis, oncology, and autoimmune conditions; pipeline programs (ADC/multispecifics) are still in early to preclinical/IND stages with parent company Celltrion

Therapeutic areas: ImmunologyGastroenterologyPulmonologyDermatologyOncology
Modalities: Monoclonal antibodyBiologicAntibody-drug conjugate
Industry: Biotech

Partnerships

Distribution partnerships with global pharmaceutical companies for indirect marketingDistribution partnership and previous collaboration with iQone Healthcare (now acquired)

Beyond the preview

Go deeper on Celltrion Healthcare Hungary.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Celltrion Healthcare Hungary.

Explore the full profile